IL-17A functions and the therapeutic use of IL-17A and IL-17RA targeted antibodies for cancer treatment-Reference-Cited by-同舟云学术

IL-17A functions and the therapeutic use of IL-17A and IL-17RA targeted antibodies for cancer treatment

Published:2023-10 Issue: Volume:123 Page:110757
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Song Meiying,Liang Jie,Wang Luoyang,Li Wei,Jiang Suli,Xu Shuo,Tang Lei,Du Qiaochu,Liu Guixian,Meng Haining,Zhai Dongchang,Shi Shangheng,Yang Yanyan,Zhang Li,Zhang Bei^ORCID

Funder

Natural Science Foundation of Shandong Province

Natural Science Foundation of Qingdao Municipality

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference183 articles.

1. Inflammation and cancer;Murata;Environ. Health Prev. Med.,2018

2. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth;Grivennikov;Nature,2012

3. Inflammation, immunity, and cancer;Singh;Med. Inflamm.,2017

4. Chronic inflammation and cytokines in the tumor microenvironment;Landskron;J. Immunol. Res.,2014

5. Cancer-related inflammation and treatment effectiveness;Diakos;Lancet Oncol.,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy for Microsatellite-Stable Metastatic Colorectal Cancer: Can we close the Gap between Potential and Practice?;Current Oncology Reports;2024-07-30

2. IL-17A Drives Oxidative Stress and Cell Growth in A549 Lung Epithelial Cells: Potential Protective Action of Oleuropein;Nutrients;2024-07-03

3. Decreased interleukin‐17RA expression is associated with good prognosis in patients with colorectal cancer and inhibits tumor growth and vascularity in mice;Cancer Medicine;2024-03

4. Pathogenic Th17 cell-mediated liver fibrosis contributes to resistance to PD-L1 antibody immunotherapy in hepatocellular carcinoma;International Immunopharmacology;2024-03